NCT04035759View on ClinicalTrials.gov

Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 16, 2019

Primary Completion Date

April 26, 2021

Study Completion Date

April 26, 2021

Conditions

HIV/AIDS

Interventions

BEHAVIORAL

APPEAL

Three-session, individually administered program, with sessions spaced monthly. Optional weekly contacts with participants to support engagement in program exercises/activities.

Trial Locations (1)

11231

SUNY Downstate Health Sciences University, Brooklyn

All Listed Sponsors

collaborator

National Institute of Nursing Research (NINR)

NIH

lead

State University of New York - Downstate Medical Center

OTHER

NCT04035759 - Positive Affect Promotion to Empower Optimal Adherence to HIV Therapy | Biotech Hunter | Biotech Hunter